{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T09:49:20Z","timestamp":1784886560325,"version":"3.55.0"},"reference-count":42,"publisher":"The Microbiological Society of Korea","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Microbiol."],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s12275-023-00014-y","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T08:03:52Z","timestamp":1675670632000},"page":"245-257","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Gut Lactobacillus and Probiotics Lactobacillus lactis\/rhamnosis Ameliorate Liver Fibrosis in Prevention and Treatment"],"prefix":"10.71150","volume":"61","author":[{"given":"Sung Min","family":"Won","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Kwang","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haripriya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satya Priya","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byoung Kook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Chae","family":"Joung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Ju","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hak","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Jun","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Tae","family":"Suk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4586","published-online":{"date-parts":[[2023,2,6]]},"reference":[{"key":"14_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cgh.2018.08.008","volume":"17","author":"C Acharya","year":"2019","unstructured":"Acharya, C., & Bajaj, J. S. (2019). Altered microbiome in patients with cirrhosis and complications. Clinical Gastroenterology and Hepatology, 17, 307\u2013321.","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"14_CR2","doi-asserted-by":"publisher","first-page":"16041","DOI":"10.1038\/nrdp.2016.41","volume":"2","author":"V Arroyo","year":"2016","unstructured":"Arroyo, V., Moreau, R., Kamath, P. S., Jalan, R., Gines, P., Nevens, F., Fernandez, J., To, U., Garcia-Tsao, G., & Schnabl, B. (2016). Acute-on-chronic liver failure in cirrhosis. Nature Reviews Disease Primers, 2, 16041.","journal-title":"Nature Reviews Disease Primers"},{"key":"14_CR3","doi-asserted-by":"publisher","first-page":"9478630","DOI":"10.1155\/2018\/9478630","volume":"2018","author":"MAK Azad","year":"2018","unstructured":"Azad, M. A. K., Sarker, M., Li, T., & Yin, J. (2018). Probiotic species in the modulation of gut microbiota: An overview. BioMed Research International, 2018, 9478630.","journal-title":"BioMed Research International"},{"key":"14_CR4","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/apt.12695","volume":"39","author":"JS Bajaj","year":"2014","unstructured":"Bajaj, J. S., Heuman, D. M., Hylemon, P. B., Sanyal, A. J., Puri, P., Sterling, R. K., Luketic, V., Stravitz, R. T., Siddiqui, M. S., Fuchs, M., Thacker, L. R., Wade, J. B., Daita, K., Sistrun, S., White, M. B., Noble, N. A., Thorpe, C., Kakiyama, G., Pandak, W. M., \u2026 Gillevet, P. M. (2014). Randomised clinical trial: Lactobacillus gg modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis. Alimentary Pharmacology & Therapeutics, 39, 1113\u20131125.","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"14_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller, R., & Brenner, D. A. (2005). Liver fibrosis. Journal of Clinical Investigation, 115, 209\u2013218.","journal-title":"Journal of Clinical Investigation"},{"key":"14_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","volume":"157","author":"Y Belkaid","year":"2014","unstructured":"Belkaid, Y., & Hand, T. W. (2014). Role of the microbiota in immunity and inflammation. Cell, 157, 121\u2013141.","journal-title":"Cell"},{"key":"14_CR7","doi-asserted-by":"publisher","first-page":"G729","DOI":"10.1152\/ajpgi.00132.2007","volume":"293","author":"IM Carroll","year":"2007","unstructured":"Carroll, I. M., Andrus, J. M., Bruno-Barcena, J. M., Klaenhammer, T. R., Hassan, H. M., & Threadgill, D. S. (2007). Anti-inflammatory properties of Lactobacillusgasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology, 293, G729-738.","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology"},{"key":"14_CR8","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2131\/jts.41.561","volume":"41","author":"S Dong","year":"2016","unstructured":"Dong, S., Chen, Q. L., Song, Y. N., Sun, Y., Wei, B., Li, X. Y., Hu, Y. Y., Liu, P., & Su, S. B. (2016). Mechanisms of ccl4-induced liver fibrosis with combined transcriptomic and proteomic analysis. The Journal of Toxicological Sciences, 41, 561\u2013572.","journal-title":"The Journal of Toxicological Sciences"},{"key":"14_CR9","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1093\/bioinformatics\/btq461","volume":"26","author":"RC Edgar","year":"2010","unstructured":"Edgar, R. C. (2010). Search and clustering orders of magnitude faster than blast. Bioinformatics, 26, 2460\u20132461.","journal-title":"Bioinformatics"},{"key":"14_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/MPG.0000000000001422","volume":"64","author":"F Famouri","year":"2017","unstructured":"Famouri, F., Shariat, Z., Hashemipour, M., Keikha, M., & Kelishadi, R. (2017). Effects of probiotics on nonalcoholic fatty liver disease in obese children and adolescents. Journal of Pediatric Gastroenterology and Nutrition, 64, 413\u2013417.","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"14_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/diseases7040058","volume":"7","author":"H Fukui","year":"2019","unstructured":"Fukui, H. (2019). Role of gut dysbiosis in liver diseases: What have we learned so far? Diseases, 7, 58.","journal-title":"Diseases"},{"key":"14_CR12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1586\/17474124.2.6.803","volume":"2","author":"Z Ghiassi-Nejad","year":"2008","unstructured":"Ghiassi-Nejad, Z., & Friedman, S. L. (2008). Advances in antifibrotic therapy. Expert Review of Gastroenterology & Hepatology, 2, 803\u2013816.","journal-title":"Expert Review of Gastroenterology & Hepatology"},{"key":"14_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/1756283X12459294","volume":"6","author":"P Hemarajata","year":"2013","unstructured":"Hemarajata, P., & Versalovic, J. (2013). Effects of probiotics on gut microbiota: Mechanisms of intestinal immunomodulation and neuromodulation. Therapeutic Advances in Gastroenterology, 6, 39\u201351.","journal-title":"Therapeutic Advances in Gastroenterology"},{"key":"14_CR14","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.3389\/fmicb.2018.01974","volume":"9","author":"CH Huang","year":"2018","unstructured":"Huang, C. H., Li, S. W., Huang, L., & Watanabe, K. (2018). Identification and classification for the Lactobacilluscasei group. Frontiers in Microbiology, 9, 1974.","journal-title":"Frontiers in Microbiology"},{"key":"14_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0262767","volume":"17","author":"P Kanmani","year":"2022","unstructured":"Kanmani, P., & Kim, H. (2022). Probiotics counteract the expression of hepatic profibrotic genes via the attenuation of tgf-beta\/smad signaling and autophagy in hepatic stellate cells. PLoS ONE, 17, e0262767.","journal-title":"PLoS ONE"},{"key":"14_CR16","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.4014\/jmb.1906.06064","volume":"29","author":"SK Kim","year":"2019","unstructured":"Kim, S. K., Guevarra, R. B., Kim, Y. T., Kwon, J., Kim, H., Cho, J. H., Kim, H. B., & Lee, J. H. (2019). Role of probiotics in human gut microbiome-associated diseases. Journal of Microbiology and Biotechnology, 29, 1335\u20131340.","journal-title":"Journal of Microbiology and Biotechnology"},{"key":"14_CR17","doi-asserted-by":"publisher","first-page":"1829449","DOI":"10.1080\/19490976.2020.1829449","volume":"12","author":"NY Lee","year":"2020","unstructured":"Lee, N. Y., Joung, H. C., Kim, B. K., Kim, B. Y., Park, T. S., & Suk, K. T. (2020a). Lactobacillus lactis ckdb001 ameliorate progression of nonalcoholic fatty liver disease through of gut microbiome: Addendum. Gut Microbes, 12, 1829449.","journal-title":"Gut Microbes"},{"key":"14_CR18","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1080\/19490976.2020.1712984","volume":"11","author":"NY Lee","year":"2020","unstructured":"Lee, N. Y., Yoon, S. J., Han, D. H., Gupta, H., Youn, G. S., Shin, M. J., Ham, Y. L., Kwak, M. J., Kim, B. Y., Yu, J. S., Lee, D. Y., Park, T. S., Park, S. H., Kim, B. K., Joung, H. C., Choi, I. S., Hong, J. T., Kim, D. J., Han, S. H., & Suk, K. T. (2020b). Lactobacillus and pediococcus ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome. Gut Microbes, 11, 882\u2013899.","journal-title":"Gut Microbes"},{"key":"14_CR19","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1002\/hep.30975","volume":"71","author":"Y Liu","year":"2020","unstructured":"Liu, Y., Chen, K., Li, F., Gu, Z., Liu, Q., He, L., Shao, T., Song, Q., Zhu, F., Zhang, L., Jiang, M., Zhou, Y., Barve, S., Zhang, X., McClain, C. J., & Feng, W. (2020). Probiotic Lactobacillusrhamnosus gg prevents liver fibrosis through inhibiting hepatic bile acid synthesis and enhancing bile acid excretion in mice. Hepatology, 71, 2050\u20132066.","journal-title":"Hepatology"},{"key":"14_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu9091021","volume":"9","author":"P Markowiak","year":"2017","unstructured":"Markowiak, P., & Slizewska, K. (2017). Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients, 9, 1\u201330.","journal-title":"Nutrients"},{"key":"14_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1443-9573.2005.00230.x","volume":"6","author":"F Marotta","year":"2005","unstructured":"Marotta, F., Barreto, R., Wu, C. C., Naito, Y., Gelosa, F., Lorenzetti, A., Yoshioka, M., & Fesce, E. (2005). Experimental acute alcohol pancreatitis-related liver damage and endotoxemia: Synbiotics but not metronidazole have a protective effect. Chinese Journal of Digestive Diseases, 6, 193\u2013197.","journal-title":"Chinese Journal of Digestive Diseases"},{"key":"14_CR22","doi-asserted-by":"publisher","first-page":"7179514","DOI":"10.1155\/2019\/7179514","volume":"2019","author":"G Mulaw","year":"2019","unstructured":"Mulaw, G., SisayTessema, T., Muleta, D., & Tesfaye, A. (2019). In vitro evaluation of probiotic properties of lactic acid bacteria isolated from some traditionally fermented Ethiopian food products. International Journal of Microbiology, 2019, 7179514.","journal-title":"International Journal of Microbiology"},{"key":"14_CR23","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.3390\/nu12092749","volume":"12","author":"MA Ortega","year":"2020","unstructured":"Ortega, M. A., Fraile-Martinez, O., Naya, I., Garcia-Honduvilla, N., Alvarez-Mon, M., Bujan, J., Asunsolo, A., & de la Torre, B. (2020). Type 2 diabetes mellitus associated with obesity (diabesity). The central role of gut microbiota and its translational applications. Nutrients, 12, 2749.","journal-title":"Nutrients"},{"key":"14_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40168-018-0440-5","volume":"6","author":"F Pan","year":"2018","unstructured":"Pan, F., Zhang, L., Li, M., Hu, Y., Zeng, B., Yuan, H., Zhao, L., & Zhang, C. (2018). Predominant gut lactobacillus murinus strain mediates anti-inflammaging effects in calorie-restricted mice. Microbiome., 6, 54.","journal-title":"Microbiome."},{"key":"14_CR25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/978-1-4939-9420-5_16","volume":"1981","author":"E Pose","year":"2019","unstructured":"Pose, E., Sancho-Bru, P., & Coll, M. (2019). 3,5-diethoxycarbonyl-1,4-dihydrocollidine diet: A rodent model in cholestasis research. Methods in Molecular Biology, 1981, 249\u2013257.","journal-title":"Methods in Molecular Biology"},{"key":"14_CR26","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/nrgastro.2017.152","volume":"14","author":"K Ray","year":"2017","unstructured":"Ray, K. (2017). Alcoholic liver disease: Gut-liver axis: Ppis, enterococcus and promotion of alcoholic liver disease. Nature Reviews Gastroenterology & Hepatology, 14, 689.","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"14_CR27","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1053\/j.gastro.2014.01.020","volume":"146","author":"B Schnabl","year":"2014","unstructured":"Schnabl, B., & Brenner, D. A. (2014). Interactions between the intestinal microbiome and liver diseases. Gastroenterology, 146, 1513\u20131524.","journal-title":"Gastroenterology"},{"key":"14_CR28","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","volume":"371","author":"D Schuppan","year":"2008","unstructured":"Schuppan, D., & Afdhal, N. H. (2008). Liver cirrhosis. The Lancet, 371, 838\u2013851.","journal-title":"The Lancet"},{"key":"14_CR29","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ijfoodmicro.2008.09.023","volume":"128","author":"S Segawa","year":"2008","unstructured":"Segawa, S., Wakita, Y., Hirata, H., & Watari, J. (2008). Oral administration of heat-killed lactobacillus brevis sbc8803 ameliorates alcoholic liver disease in ethanol-containing diet-fed c57bl\/6n mice. International Journal of Food Microbiology, 128, 371\u2013377.","journal-title":"International Journal of Food Microbiology"},{"key":"14_CR30","doi-asserted-by":"publisher","first-page":"62","DOI":"10.7812\/TPP\/12-144","volume":"17","author":"V Sharma","year":"2013","unstructured":"Sharma, V., Garg, S., & Aggarwal, S. (2013). Probiotics and liver disease. The Permanente Journal, 17, 62\u201367.","journal-title":"The Permanente Journal"},{"key":"14_CR31","doi-asserted-by":"publisher","first-page":"6927","DOI":"10.1038\/s41598-017-07091-1","volume":"7","author":"D Shi","year":"2017","unstructured":"Shi, D., Lv, L., Fang, D., Wu, W., Hu, C., Xu, L., Chen, Y., Guo, J., Hu, X., Li, A., Guo, F., Ye, J., Li, Y., Andayani, D., & Li, L. (2017). Administration of Lactobacillus salivarius li01 or Pediococcus pentosaceus li05 prevents ccl4-induced liver cirrhosis by protecting the intestinal barrier in rats. Scientific Reports, 7, 6927.","journal-title":"Scientific Reports"},{"key":"14_CR32","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.jhep.2015.02.039","volume":"62","author":"C Trautwein","year":"2015","unstructured":"Trautwein, C., Friedman, S. L., Schuppan, D., & Pinzani, M. (2015). Hepatic fibrosis: Concept to treatment. Journal of Hepatology, 62, S15-24.","journal-title":"Journal of Hepatology"},{"key":"14_CR33","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3389\/fmicb.2011.00190","volume":"2","author":"PJ Turnbaugh","year":"2011","unstructured":"Turnbaugh, P. J., & Stintzi, A. (2011). Human health and disease in a microbial world. Frontiers in Microbiology, 2, 190.","journal-title":"Frontiers in Microbiology"},{"key":"14_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.phrs.2012.09.008","volume":"69","author":"AW Walker","year":"2013","unstructured":"Walker, A. W., & Lawley, T. D. (2013). Therapeutic modulation of intestinal dysbiosis. Pharmacological Research, 69, 75\u201386.","journal-title":"Pharmacological Research"},{"key":"14_CR35","first-page":"1569","volume":"12","author":"H Wang","year":"2020","unstructured":"Wang, H., Zhou, C., Huang, J., Kuai, X., & Shao, X. (2020). The potential therapeutic role of Lactobacillusreuteri for treatment of inflammatory bowel disease. American Journal of Translational Research, 12, 1569\u20131583.","journal-title":"American Journal of Translational Research"},{"key":"14_CR36","first-page":"85","volume":"110","author":"J Wiegand","year":"2013","unstructured":"Wiegand, J., & Berg, T. (2013). The etiology, diagnosis and prevention of liver cirrhosis: Part 1 of a series on liver cirrhosis. Deutsches \u00c4rzteblatt International, 110, 85\u201391.","journal-title":"Deutsches \u00c4rzteblatt International"},{"key":"14_CR37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","volume":"214","author":"TA Wynn","year":"2008","unstructured":"Wynn, T. A. (2008). Cellular and molecular mechanisms of fibrosis. Journal of Pathology, 214, 199\u2013210.","journal-title":"Journal of Pathology"},{"key":"14_CR38","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm.2807","volume":"18","author":"TA Wynn","year":"2012","unstructured":"Wynn, T. A., & Ramalingam, T. R. (2012). Mechanisms of fibrosis: Therapeutic translation for fibrotic disease. Nature Medicine, 18, 1028\u20131040.","journal-title":"Nature Medicine"},{"key":"14_CR39","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ejphar.2006.01.001","volume":"532","author":"JT Xie","year":"2006","unstructured":"Xie, J. T., Shao, Z. H., Vanden Hoek, T. L., Chang, W. T., Li, J., Mehendale, S., Wang, C. Z., Hsu, C. W., Becker, L. B., Yin, J. J., & Yuan, C. S. (2006). Antioxidant effects of ginsenoside re in cardiomyocytes. European Journal of Pharmacology, 532, 201\u2013207.","journal-title":"European Journal of Pharmacology"},{"key":"14_CR40","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00204-015-1543-4","volume":"90","author":"SC Yanguas","year":"2016","unstructured":"Yanguas, S. C., Cogliati, B., Willebrords, J., Maes, M., Colle, I., van den Bossche, B., de Oliveira, C., Andraus, W., Alves, V. A. F., Leclercq, I., & Vinken, M. (2016). Experimental models of liver fibrosis. Archives of Toxicology, 90, 1025\u20131048.","journal-title":"Archives of Toxicology"},{"key":"14_CR41","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1099\/ijsem.0.001755","volume":"67","author":"SH Yoon","year":"2017","unstructured":"Yoon, S. H., Ha, S. M., Kwon, S., Lim, J., Kim, Y., Seo, H., & Chun, J. (2017). Introducing ezbiocloud: A taxonomically united database of 16s rrna gene sequences and whole-genome assemblies. International Journal of Systematic and Evolutionary Microbiology, 67, 1613\u20131617.","journal-title":"International Journal of Systematic and Evolutionary Microbiology"},{"key":"14_CR42","doi-asserted-by":"publisher","first-page":"7493","DOI":"10.3390\/ijms16047493","volume":"16","author":"YJ Zhang","year":"2015","unstructured":"Zhang, Y. J., Li, S., Gan, R. Y., Zhou, T., Xu, D. P., & Li, H. B. (2015). Impacts of gut bacteria on human health and diseases. International Journal of Molecular Sciences, 16, 7493\u20137519.","journal-title":"International Journal of Molecular Sciences"}],"container-title":["Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12275-023-00014-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12275-023-00014-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12275-023-00014-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T17:52:11Z","timestamp":1735062731000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12275-023-00014-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["14"],"URL":"https:\/\/doi.org\/10.1007\/s12275-023-00014-y","relation":{},"ISSN":["1225-8873","1976-3794"],"issn-type":[{"value":"1225-8873","type":"print"},{"value":"1976-3794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"4 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest, including relevant financial interests, activities, relationships, affiliations, and any other conflict of interest as explicitly and implicitly expressed in the Editorial Policies for Authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was controlled in accordance with ethical guidelines from the 1975 Helsinki Declaration as reflected by prior approval by the institutional review notice for human research in the hospital participating in the trial (2016-134). Basic information has been registered on ClinicalTrials.gov for registration in the public trial registry (NCT04339725). Informed consent for enrollment was received from each participant. This experiment was designed by selecting a candidate for the treatment of liver disease among the probiotics that approved by Ministry of Food and Drug Safety, Korean. All the procedures were licensed by the Institutional Animal Care and Use Committee of the College of Medicine, Hallym University R1(2019-04).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}